drugset / Trial / NCT04497792
Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions
Phase 4
Completed
40 enrolled
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
RandomizedParallel-groupOpen-labelTreatment
Summary
Aim: To study the effectiveness and safety of empagliflozin as a preoperative preparation tool, as well as to improve the long-term prognosis of planned percutaneous coronary interventions in patients with type 2 diabetes
Timeline
- Start
- 2016-11
- Primary completion
- 2018-11
- Completion
- 2019-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 10 mg | — |
| Background | Metformin | Small molecule | — | — |